Pazopanib in Patients with Clear-Cell Renal Cell Carcinoma: Seeking the Right Patient

Bibliographic Details
Main Authors: Camillo Porta, Alessandra Ferrari, Anna M. Czarnecka, Cezary A. Szczylik
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-06-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fphar.2017.00329/full
_version_ 1828726489626968064
author Camillo Porta
Camillo Porta
Alessandra Ferrari
Anna M. Czarnecka
Cezary A. Szczylik
author_facet Camillo Porta
Camillo Porta
Alessandra Ferrari
Anna M. Czarnecka
Cezary A. Szczylik
author_sort Camillo Porta
collection DOAJ
first_indexed 2024-04-12T13:44:03Z
format Article
id doaj.art-ab120489e6564076b81884c00179e933
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-12T13:44:03Z
publishDate 2017-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-ab120489e6564076b81884c00179e9332022-12-22T03:30:46ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122017-06-01810.3389/fphar.2017.00329266500Pazopanib in Patients with Clear-Cell Renal Cell Carcinoma: Seeking the Right PatientCamillo Porta0Camillo Porta1Alessandra Ferrari2Anna M. Czarnecka3Cezary A. Szczylik4Medical Oncology, San Matteo University Hospital Foundation (IRCCS)Pavia, ItalyItalian Group of Onco-Nephrology (GION)Pavia, ItalyMedical Oncology, San Matteo University Hospital Foundation (IRCCS)Pavia, ItalyDepartment of Oncology with Laboratory of Molecular Oncology, Military Institute of MedicineWarsaw, PolandDepartment of Oncology with Laboratory of Molecular Oncology, Military Institute of MedicineWarsaw, Polandhttp://journal.frontiersin.org/article/10.3389/fphar.2017.00329/fullangiogenesis inhibitorclear cell renal carcinomapazopanibreal-worldpoor risk
spellingShingle Camillo Porta
Camillo Porta
Alessandra Ferrari
Anna M. Czarnecka
Cezary A. Szczylik
Pazopanib in Patients with Clear-Cell Renal Cell Carcinoma: Seeking the Right Patient
Frontiers in Pharmacology
angiogenesis inhibitor
clear cell renal carcinoma
pazopanib
real-world
poor risk
title Pazopanib in Patients with Clear-Cell Renal Cell Carcinoma: Seeking the Right Patient
title_full Pazopanib in Patients with Clear-Cell Renal Cell Carcinoma: Seeking the Right Patient
title_fullStr Pazopanib in Patients with Clear-Cell Renal Cell Carcinoma: Seeking the Right Patient
title_full_unstemmed Pazopanib in Patients with Clear-Cell Renal Cell Carcinoma: Seeking the Right Patient
title_short Pazopanib in Patients with Clear-Cell Renal Cell Carcinoma: Seeking the Right Patient
title_sort pazopanib in patients with clear cell renal cell carcinoma seeking the right patient
topic angiogenesis inhibitor
clear cell renal carcinoma
pazopanib
real-world
poor risk
url http://journal.frontiersin.org/article/10.3389/fphar.2017.00329/full
work_keys_str_mv AT camilloporta pazopanibinpatientswithclearcellrenalcellcarcinomaseekingtherightpatient
AT camilloporta pazopanibinpatientswithclearcellrenalcellcarcinomaseekingtherightpatient
AT alessandraferrari pazopanibinpatientswithclearcellrenalcellcarcinomaseekingtherightpatient
AT annamczarnecka pazopanibinpatientswithclearcellrenalcellcarcinomaseekingtherightpatient
AT cezaryaszczylik pazopanibinpatientswithclearcellrenalcellcarcinomaseekingtherightpatient